Description
Cancer is the leading cause of death in 45-47% of dogs over the age of 10 years old. About one third of these incidents are related to subcutaneous or dermal neoplasia. Cancer diagnosis at an earlier stage is key in treatment planning. Furthermore, the ability to easily diagnose early-stage neoplasia in general practices should improve patient welfare and prognosis dramatically.
The current guidelines for cancer diagnosis emphasise the need for a diagnostic plan rather than base one’s decision on history and palpation of the mass alone.
In this lecture we will introduce our innovative non-invasive screening tool, using Heat Diffusion Imaging (HDI) technology and an AI-based analysis, which promotes early detection of cancer and allows vets and nurse to rule out cancer on-the-spot in their own practice or alert if further investigation is required.
Additionally, we will be sharing interesting case studies, which demonstrate the key clinical values of the HT Vista in assisting clinicians in making informed and evidence-based decisions for their canine patients.
Learning objectives of this webinar:
• Explore the current approach for diagnosing subcutaneous and dermal cancer in dogs in general practice.
• Share the outcome of a recent survey looking at clinicians' perception and preferences when presented with dermal and subcutaneous masses in dogs.
• Introduce the HT Vista technology, a new non-invasive approach for cancer screening of subcutaneous and dermal masses in dogs.
• Demonstrate the values and clinical usage of HT Vista in the clinical setting via key case studies.
• Share the approach that all dermal and subcutaneous masses in dogs must be investigated and no mass should be left undiagnosed.
• Share the approach that it is impossible to rule out cancer based on history and palpation alone.
